Trials / Unknown
UnknownNCT00914654
Concentrations of Formoterol in Blood and Urine
Blood and Urinary Concentrations of Inhaled Formoterol in Asthmatic Subjects and Elite Athletes With Asthma
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the blood and urine concentrations of inhaled formoterol.
Detailed description
The purpose of the study is to assess the serum and urine concentrations after inhalation of 18 microgram formoterol as one dose. Furthermore to investigate the serum and urine concentrations of inhaled formoterol and evaluate the difference between three groups: healthy men, male asthmatic subjects and male elite athletes with asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | inhaled formoterol | Inhalation of 18 microgram formoterol as one dose. Oxis Turbohaler 9 microg/dose, MA no. 30072. |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-06-05
- Last updated
- 2009-06-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00914654. Inclusion in this directory is not an endorsement.